Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
BPC-157 is also named on WADA's Prohibited List under section S0 (Non-Approved Substances), the first time WADA named a specific substance by name as an example within that category (added for the 2022 List)
However, based on the pharmacological similarity to other incretin-based therapies, similar weight regain is expected once treatment ends
Mild nausea or early fullness can show up and often settles over a few weeks
Struggle with weight management and are seeking a metabolism boost
The lipotropic compounds help mobilize and metabolize fat, while B12 supports energy and the metabolism of fats, proteins, and carbohydrates
US$ 21.91
US$ 20.34
US$ 27.21
US$ 20.18
US$ 28.09
US$ 22.49
US$ 27.00
US$ 29.02
